Ftse Mib
34.684,21
-0,43%
DAX
18.557,27
-0,48%
S&P 500
5.351,51
-0,03%
NASDAQ
17.136,18
-0,22%
Bitcoin
69.175,44
-2,24%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Insmed Inc (INSM) Insmed Inc (INSM) Notizie

INSM

Insmed (INSM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INSM
DataOraFonteTitoloSimboloCompagnia
07/06/202414:00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
05/06/202422:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
05/06/202414:00PR Newswire (US)Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
04/06/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
03/06/202422:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
30/05/202422:05PR Newswire (US)Insmed to Host Commercial Webinar on June 4, 2024NASDAQ:INSMInsmed Inc
30/05/202422:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INSMInsmed Inc
30/05/202414:00PR Newswire (US)Insmed Announces Pricing of $650 Million Public Offering of Common StockNASDAQ:INSMInsmed Inc
29/05/202400:21PR Newswire (US)Insmed Announces Proposed $500 Million Public Offering of Common StockNASDAQ:INSMInsmed Inc
28/05/202412:30PR Newswire (US)Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
27/05/202422:00PR Newswire (US)Insmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
20/05/202422:28PR Newswire (US)Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International ConfeNASDAQ:INSMInsmed Inc
14/05/202422:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INSMInsmed Inc
09/05/202413:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INSMInsmed Inc
09/05/202413:00PR Newswire (US)Insmed Reports First-Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
07/05/202414:00PR Newswire (US)Insmed To Present at the BofA Securities Health Care Conference 2024NASDAQ:INSMInsmed Inc
25/04/202414:00PR Newswire (US)Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024NASDAQ:INSMInsmed Inc
27/03/202421:05PR Newswire (US)Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International ConferenceNASDAQ:INSMInsmed Inc
29/02/202414:00PR Newswire (US)Insmed To Present at Three March ConferencesNASDAQ:INSMInsmed Inc
28/02/202422:05PR Newswire (US)Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their HealthNASDAQ:INSMInsmed Inc
22/02/202413:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INSMInsmed Inc
22/02/202413:00PR Newswire (US)Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
16/02/202423:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INSMInsmed Inc
14/02/202416:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:INSMInsmed Inc
08/02/202414:00PR Newswire (US)Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024NASDAQ:INSMInsmed Inc
05/01/202414:00PR Newswire (US)Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
02/01/202414:00PR Newswire (US)Insmed To Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
29/11/202314:00PR Newswire (US)Insmed To Present at the Nasdaq 49th Investor ConferenceNASDAQ:INSMInsmed Inc
08/11/202314:00PR Newswire (US)Insmed To Present at Two November ConferencesNASDAQ:INSMInsmed Inc
02/11/202313:00PR Newswire (US)Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the GlobeNASDAQ:INSMInsmed Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INSM

La tua Cronologia

COIN
CSTLGBP
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network